We read the provocative article by Franks et al. with great interest, because it concludes that since the 1998 Master Settlement Agreement (MSA) between states and tobacco companies, there has been a "dramatic decline in the effect of cigarette pack prices on smoking participation in both lower-and higherincome individuals." 1(p1876) We were impressed with the authors' thoughtful analytic approach but remained skeptical because their results contradict a large body of previous research.
A meta-analysis examined 523 estimates of price effects and confirmed the conventional wisdom that a 10% increase in cigarette prices leads to a 4% decline in smoking. First, we pursued the possibility the authors raise that the prices they used may have overstated actual prices by failing to capture price promotions after the MSA. Second, individual studies can produce varying estimates. We reanalyzed the data in Franks et al. with a few modifications. We included 2 additional years of data after the MSA and limit the pre-MSA period from 1990 to October 1998. Earlier years were dropped because too few states are represented in the BRFSS in the 1980s-as few as 15. In 1990, 45 states participated. We also examined the effects for 3 income groups: the lowest income quartile, the middle two income quartiles, and the highest income quartile. Aside from these differences, our analytic approach was nearly identical to that of Franks et al. Table 1 shows a statistically significant overall effect of cigarette prices on smoking prevalence before and after the MSA. These results do suggest that the size of the price effect has declined, but only among the middle and high income groups. A 10% increase in price would lead to a 0.9% decline in the prevalence of smoking overall, a 1.1% decline among the lowest income group, and a 0.6% decline in the 2 middle income groups. The latter effect is marginally statistically significant, although there is not a statistically significant effect for the highest income group. From a public health standpoint, cigarette excise taxes continue to be an important option for policymakers for several reasons. First, our results confirm the large body of research that shows that increasing the price of cigarettes discourages smoking, with larger effects among low-income smokers. Second, concerns about the regressivity of cigarette excise taxes can easily be addressed, as suggested by noted health economist Kenneth Warner, by earmarking revenue from cigarette excise taxes to evidence-based smoking cessation interventions targeted to low income populations with the highest smoking rates. Such a combined policy may actually be considered a progressive health policy solution. Finally, what may appear to be modest effects of increases in cigarette prices can lead to millions of smokers quitting.
Based on the literature cited in this letter, a 25% increase in the price of cigarettes nationally would lead to a 5% decline in the prevalence of smoking. With 47 million smokers in the United States as of 2006, this decline translates to 2 million fewer smokers-a significant public health impact. With additional dedicated cessation assistance for low-income smokers, this number would increase further. 
